Mahomed S, Garrett N, Capparelli EV, Osman F, Harkoo I, Yende-Zuma N, et al. Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention. J Infect Dis. 2022;226(3):510-20. https://academic.oup.com/jid/article/226/3/510/6522857
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
By Peter Matlawa|2023-03-06T09:25:49+02:00February 23, 2023|2022: July to September|Comments Off on Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys(®) cortisol II assay: a pilot study.